Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Treating bilateral knee osteoarthritis with sustained acoustic medicine reduces pain, restores function for 76-year-old man.

A bacterial molecule enhances chemotherapy. Its synthetic form could inspire new cancer drugs. An international group of researchers, led by teams at the MRC (LMS), Imperial College London, and the ...

The 2025 European Society for Medical Oncology (ESMO) Congress will take place in Berlin, Germany, from October 17 to 21. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech”, HKEX: 6990 ...

Revvity, Inc. (NYSE: RVTY) announced a strategic collaboration with Profluent , bringing together a range of its novel AI-engineered enzymes with Revvity’s established Pin-point TM base editing ...

CDMO industry experts explain evolving demand, regulatory shifts, and analytical challenges shaping the HPAPI contract ...

The landscape of antibacterial therapies in India is evolving to address the antimicrobial resistance (AMR). Many research centres are exploring alternative antibacterial therapies. By adopting ...

From plant-based clean-label ingredients to innovative delivery formats, discover the latest breakthroughs in nutraceutical formulations that boost bioavailability and quality!

Fig 1. Summary of key guideline recommendations. ADT, androgen deprivation therapy; ARPI, androgen receptor pathway inhibitor; C, conditional; CRPC, castration ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

uniQure N.V. (NASDAQ:QURE) on Friday released initial safety and exploratory efficacy data from the first cohort of its Phase 1/2a trial of AMT-191, an investigational gene therapy for Fabry disease.

The new prime editors are about as efficient as their predecessors but make up to 60-fold fewer ‘indel’ mistakes.